Home Cart Sign in  
Chemical Structure| 58-58-2 Chemical Structure| 58-58-2

Structure of Puromycin 2HCl
CAS No.: 58-58-2

Chemical Structure| 58-58-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Puromycin 2HCl is an aminonucleoside antibiotic, which acts as a protein synthesis inhibitor.

Synonyms: CL13900 dihydrochloride; Puromycin(hydrochloride); PDH

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Puromycin 2HCl

CAS No. :58-58-2
Formula : C22H31Cl2N7O5
M.W : 544.43
SMILES Code : OC[C@@H]1[C@@H](NC([C@@H](N)CC2=CC=C(OC)C=C2)=O)[C@H]([C@H](N3C=NC4=C3N=CN=C4N(C)C)O1)O.[H]Cl.[H]Cl
Synonyms :
CL13900 dihydrochloride; Puromycin(hydrochloride); PDH
MDL No. :MFCD00012691
InChI Key :MKSVFGKWZLUTTO-FZFAUISWSA-N
Pubchem ID :443311

Safety of Puromycin 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312+P330-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CD4+ T cells 5 μg/mL Inhibited the proliferation of CD4+ T cells and reduced their pathogenicity Nat Commun. 2022 Oct 4;13(1):5866.
Mouse primary myotubes 10 μg/mL 10 min To measure protein synthesis levels, results showed increased puromycin incorporation, indicating enhanced protein synthesis. Skelet Muscle. 2019 Oct 31;9(1):26.
E14 mouse embryonic stem cells 1 μg/ml 48 h To select clones transduced with Nm-gRNA Cell Death Discov. 2023 Feb 13;9(1):61.
FaDu cells 2 μg/ml 1 week To screen stably silenced and overexpressed IGF2BP2 HNSCC cells J Exp Clin Cancer Res. 2022 Jan 3;41(1):6.
SCC15 cells 2 μg/ml 1 week To screen stably silenced and overexpressed IGF2BP2 HNSCC cells J Exp Clin Cancer Res. 2022 Jan 3;41(1):6.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Experimental autoimmune uveitis (EAU) model Added to the culture medium 5 μg/mL Used to select transduced cells and inhibit the proliferation of CD4+ T cells Nat Commun. 2022 Oct 4;13(1):5866.
Mice SCID mice Intraperitoneal injection 0.040 μM Single injection, lasting 30 minutes To measure muscle protein synthesis levels, results showed increased puromycin incorporation, indicating enhanced protein synthesis. Skelet Muscle. 2019 Oct 31;9(1):26.
Mouse LONP1 mKO mice Intraperitoneal injection 0.04 mmol/g Single injection, lasting 30 minutes Measure in vivo protein synthesis rates Nat Commun. 2022 Feb 16;13(1):894
Mice SIRT6 heterozygous mice Intraperitoneal injection 40 nmol/g Single injection, sacrificed after 30 minutes To measure in vivo protein synthesis rates Nucleic Acids Res. 2019 Sep 26;47(17):9115-9131

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01132183 Healthy Phase 1 Completed - India ... More >> Bioserve Clinical Research Pvt. Ltd. Hyd, Andhra Pradesh, India, 500 037 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.84mL

0.37mL

0.18mL

9.18mL

1.84mL

0.92mL

18.37mL

3.67mL

1.84mL

References

 

Historical Records

Categories